The grades of four Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
-
-
Sponsored By:
-
Sponsored By:
BMY
4 Pharmaceutical Stocks to Buy Now
The grades of four Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More
38 Ways to Prepare For Market Choppiness
Monday's trading day saw some losses due to events in Cyprus, and keeping posted on changes to stock picks is a critical part of riding out the choppiness. More
4 Pharmaceutical Stocks to Buy Now
This week, four Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
Tech IPOs Come to Life: 2 Deals on Deck
Just after a hot IPO from Silver Spring Networks, two more tech names -- Marin Software and Model N -- are slated to hit the market next week. More
Blue Chips Making Waves and Changing Ratings
With the runup in the markets over the past week a lot has changed in the valuations of companies. Take a look at our latest listing to find out where we stand More
4 Pharmaceutical Stocks to Buy Now
This week, four Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
